Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Patient-reported outcomes (PROs) capture the patient voice and have been associated with improved clinical outcomes in oncology, but their prognostic and predictive value remains underutilized due to challenges in interpreting these highly variable and noisy PRO data. Here, we developed a quantitative modeling framework integrating nonlinear mixed-effects (NLME) and item response theory (IRT) to c...
The HIV reservoir that establishes early upon infection and persists in tissues remains the primary barrier to a functional cure. While progress has been made to study the reservoir in blood compartments and specific cell types, knowledge gaps remain on the tissue microenvironment that facilitates persistence. The development of a novel immunoPET/CT-guided spatial transcriptomics pipeline has enab...
Large language models (LLMs) show promise in radiology but their deployment is limited by computational requirements that preclude use in resource-con...
Single-cell foundation models (scFMs) have shown promise as transferable representations of cellular state, but recent zero-shot evaluations suggest t...
Adverse drug effects remain a major barrier to safe and effective cancer therapy, underscoring the need for tools that predict treatment-related toxic...
Gastric cancer patients frequently experience skeletal muscle loss during the perioperative and adjuvant treatment period, which has been associated w...
Second generation antiandrogens, such as enzalutamide, are commonly prescribed to treat advanced prostate cancer. However, enzalutamide resistant pros...
Enzyme kinetic parameters underpin mechanistic biology but remain sparse in physiological context. We present EnzCast, a multi-modal framework jointly...
Surgical resection remains the only potentially curative treatment for pancreatic ductal adenocarcinoma (PDAC), and eligibility depends on accurate as...
Peritoneal metastases are currently assessed using diagnostic laparoscopy to determine Sugarbaker's Peritoneal Cancer Index (sPCI), which works by div...
BACKGROUND: Autism spectrum disorder (ASD) is marked by profound neurobiological heterogeneity, which drives inconsistent neuroimaging findings and im...
Background: Identification of metastasis status in non-small cell lung cancer (NSCLC) is a critical part of understanding disease prognosis, treatment...
Accurate intraoperative assessment of glioma infiltration is essential for maximizing tumor resection while preserving functional brain tissue. Fluore...
Melanocytes become cancerous, forming tumors that may invade and destroy the surrounding tissues. When melanocytes acquire invasive characteristics, t...
Understanding cellular responses to genetic perturbations is fundamental for drug discovery, yet experimental approaches face significant limitations ...
Diffuse Large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma in the Western world. First-line immunochemotherapy fails in approximatel...
Thyroid cancer is a heterogeneous malignancy with variable outcomes, highlighting the need for reliable biomarkers and effective risk stratification. ...
Motivation: Multi-omics integration can improve cancer subtyping, but modality informativeness and noise vary across cancer types and patients. Existi...
Accurate whole-cell and nuclear segmentation is essential for precision pathology and spatial omics, yet routine hematoxylin and eosin (H&E) staining ...
The molecular characterization of human solid growths has introduced immense genomic complexity and intra-tumoral diversification. Converting these de...